Tetrahydrocannabinol (THC)

In this month’s webinar, Dr. Sulak discusses new studies on various effects and risks of cannabis on driving performance.

Dr. Dustin Sulak reviews studies on medical cannabis in this month’s webinar, including research on Tourette syndrome, chemotherapy-induced neuropathy, and caregiver wellbeing.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

The researchers measured the amount of THC and other cannabinoids on participants’ breaths, with results demonstrating an increase in THC concentration from baseline samples.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Despite federal hurdles, WSU researchers at the Center for Cannabis Policy Research and Outreach (CCPRO) are expanding cannabis science and collaboration.

Industry organizations respond after Governor Greg Abbott vetoed SB 3, citing safety and legal concerns.

The study tested the effects of real-world cannabis products categorized by four modes of administration: dabbing, vaping, bong-like, or joint-like products.

The effect of orally ingested cannabis on information processing speed, sustained and divided attention, inhibitory control, and mental flexibility was measured.

Here, we bring you our top five recent articles covering cannabis testing regulations, water usage in indoor cultivation, the PREPARE Act, delta-8-THC research, and a new grant program from the Minnesota Office of Cannabis Management.

A recent study showed that orally administered Delta-8 THC had similar but milder effects than Delta-9 THC.

Here, we bring you our top four recent articles covering research on cannabis and multiple sclerosis, New York’s Responsible Workforce Training program, veteran use of natural products, and testimony from the US Hemp Roundtable.

A recent study explored how vaporized cannabis consisting of a standardized THC and CBD formulation may help improve symptoms of MS patients.

The study measured children’s exposure to in-home cannabis smoke through biomarkers in urine samples.

Check out the complete series from our Cannabis Analysis column.

Here, Scott Mazza, Founder of Vitality CBD, discusses what science and law say about the cannabinoid THCA.

Here, we discuss how to perform a validation, how to calculate the Standard Error of Prediction, and the best metric of calibration quality.

This article examines what rescheduling cannabis would involve, the implications for various sectors, and the potential roadblocks that could arise along the way.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Products containing Delta-8 THC may be leading to an increase in calls to poison control centers, according to a recent study.

This article provides an analysis of current regulations and proposed changes that could impact the hemp industry.

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Here, we discuss the importance of calibration metrics and how to measure calibration quality.